Literature DB >> 21225308

Diffuse alveolar hemorrhage in lupus nephritis complicated by microscopic polyangiitis.

Motohide Isono1, Hisazumi Araki, Takao Haitani, Yoshikata Morita, Mako Yasuda, Noriko Kato, Koji Urasaki, Yoshinori Tsujimura.   

Abstract

Diffuse alveolar hemorrhage (DAH) is a rare but fatal complication in patients with systemic lupus erythematosus (SLE). We describe a case of a 74-year-old woman who presented with DAH as an initial presentation of SLE. She also had microscopic polyangiitis clinically manifesting as crescentic glomerulonephritis and purpura with positive myeloperoxidase (MPO)-antineutrophil cytoplasmic antibodies (ANCA). The patient transiently improved when treated with plasma exchange and methylprednisolone pulse therapy; however, she died of recurrent pulmonary hemorrhage and concurrent cryptococcal pneumonia. This case indicates that MPO-ANCA is associated with severe organ involvement such as pulmonary hemorrhage and crescentic glomerulonephritis in SLE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21225308     DOI: 10.1007/s10157-010-0394-9

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  25 in total

1.  Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.

Authors:  M Boes; T Schmidt; K Linkemann; B C Beaudette; A Marshak-Rothstein; J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus.

Authors:  D Sen; David A Isenberg
Journal:  Lupus       Date:  2003       Impact factor: 2.911

3.  Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations.

Authors:  A R Fauzi; N C T Kong; M K Chua; V Jeyabalan; M N Idris; R Azizah
Journal:  Med J Malaysia       Date:  2004-08

4.  Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations.

Authors:  I Manolova; M Dancheva; K Halacheva
Journal:  Rheumatol Int       Date:  2001-07       Impact factor: 2.631

Review 5.  Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis.

Authors:  Philip J Klemmer; W Chalermskulrat; Michael S Reif; Susan L Hogan; David C Henke; Ronald J Falk
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

6.  Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity.

Authors:  Samih H Nasr; Vivette D D'Agati; Hye-Ran Park; Paul L Sterman; Juan D Goyzueta; Robert M Dressler; Shawn M Hazlett; Robert N Pursell; Christopher Caputo; Glen S Markowitz
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 8.237

7.  Development of selective IgM deficiency in systemic lupus erythematosus patients with disease of long duration.

Authors:  O Saiki; Y Saeki; T Tanaka; S Doi; H Hara; S Negoro; T Igarashi; S Kishimoto
Journal:  Arthritis Rheum       Date:  1987-11

8.  Intrapulmonary hemorrhage in collagen-vascular diseases includes a spectrum of underlying conditions.

Authors:  Shoko Kobayashi; Shigeko Inokuma
Journal:  Intern Med       Date:  2009-06-01       Impact factor: 1.271

9.  Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE.

Authors:  M Galeazzi; G Morozzi; G D Sebastiani; F Bellisai; R Marcolongo; R Cervera; E De Ramòn Garrido; A Fernandez-Nebro; F Houssiau; A Jedryka-Goral; A Mathieu; C Papasteriades; J C Piette; R Scorza; J Smolen
Journal:  Clin Exp Rheumatol       Date:  1998 Sep-Oct       Impact factor: 4.473

10.  Microangiitis in lupus-induced pulmonary hemorrhage.

Authors:  J L Myers; A A Katzenstein
Journal:  Am J Clin Pathol       Date:  1986-05       Impact factor: 2.493

View more
  4 in total

1.  AP-VAS 2012 case report: a case of lupus nephritis with predominant synchronous cellular crescent formation and myeloperoxidase-antineutrophil cytoplasmic antibody seropositivity.

Authors:  Tetsuya Makiishi; Tomoyuki Shirase; Shinya Yamamoto; Sayako Maeda
Journal:  CEN Case Rep       Date:  2013-01-30

2.  Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis.

Authors:  Pierre-Andre Jarrot; Laurent Chiche; Baptiste Hervier; Laurent Daniel; Vincent Vuiblet; Nathalie Bardin; Daniel Bertin; Benjamin Terrier; Zahir Amoura; Emmanuel Andrés; Eric Rondeau; Mohamed Hamidou; Jean-Loup Pennaforte; Philippe Halfon; Eric Daugas; Bertrand Dussol; Xavier Puéchal; Gilles Kaplanski; Noemie Jourde-Chiche
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

3.  Anti-Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis.

Authors:  S W Olson; J J Lee; M Poirier; D J Little; L K Prince; T P Baker; J D Edison; K C Abbott
Journal:  Autoimmune Dis       Date:  2017-12-24

4.  Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody.

Authors:  Shuai Wang; Jin Shang; Jing Xiao; Zhanzheng Zhao
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.